Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1980 Jul;44(1):25–29. doi: 10.1136/hrt.44.1.25

Excessive plasma dopamine increase at rest and during exercise after long-term beta-adrenoreceptor blockade in hypertensive patients.

I W Franz, F W Lohmann, G Koch
PMCID: PMC482355  PMID: 7426157

Full text

PDF
25

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Franz I. W., Lohmann F. W., Koch G. Differential effects of long-term cardioselective and nonselective beta-receptor blockade on plasma catecholamines during and after physical exercise in hypertensive patients. J Cardiovasc Pharmacol. 1980 Jan-Feb;2(1):35–44. doi: 10.1097/00005344-198001000-00005. [DOI] [PubMed] [Google Scholar]
  2. Franz I. W., Lohmann F. W., Koch G., Röcker L. Der Einfluss sogenannter kardioselektiver und nichtkardioselektiver beta-Rezeptorenblocker auf den Stoffwechsel während ergometrischer Leistung bei Hypertoniepatienten. Verh Dtsch Ges Inn Med. 1978;(84):813–816. [PubMed] [Google Scholar]
  3. Galbo H., Holst J. J., Christensen N. J., Hilsted J. Glucagon and plasma catecholamines during beta-receptor blockade in exercising man. J Appl Physiol. 1976 Jun;40(6):855–863. doi: 10.1152/jappl.1976.40.6.855. [DOI] [PubMed] [Google Scholar]
  4. Goldberg L. I. Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev. 1972 Mar;24(1):1–29. [PubMed] [Google Scholar]
  5. Grobecker H., Planz G., Wiethold G., Simrock R., Becker H. J., Lutz E., Petersen P. Spezifische und unspezifische Wirkungen von beta-Sympatholytika am Menschen. Klin Wochenschr. 1976 Aug 15;54(16):783–788. doi: 10.1007/BF01614295. [DOI] [PubMed] [Google Scholar]
  6. Irving M. H., Britton B. J., Wood W. G., Padgham C., Carruthers M. Effects of beta adrenergic blockade on plasma catecholamines in exercise. Nature. 1974 Apr 5;248(448):531–533. doi: 10.1038/248531a0. [DOI] [PubMed] [Google Scholar]
  7. Koch G. Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoreceptor blockade by labetalol. Br Heart J. 1979 Feb;41(2):192–198. doi: 10.1136/hrt.41.2.192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Koch G., Johansson U., Arvidsson E. Radioenzymatic determination of epinephrine, norepinephrine and dopamine in 0.1 ml plasma samples: plasma catecholamine response to submaximal and near maximal exercise. J Clin Chem Clin Biochem. 1980 Jun;18(6):367–372. doi: 10.1515/cclm.1980.18.6.367. [DOI] [PubMed] [Google Scholar]
  9. Kolloch R., Stumpe K. O., Higuchi M., Vetter H., Krück F. Erhöhte Plasma-Prolactin-Konzentration bei essentieller Hypertension: Index einer verminderten hypothalamischen dopaminergen Aktivität. Klin Wochenschr. 1977 Oct 15;55(20):1013–1018. doi: 10.1007/BF01488188. [DOI] [PubMed] [Google Scholar]
  10. MCDONALD R. H., Jr, GOLDBERG L. I., MCNAY J. L., TUTTLE E. P., Jr EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW. J Clin Invest. 1964 Jun;43:1116–1124. doi: 10.1172/JCI104996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ramdohr B., Biamino G., Schŭren K. P., Schroder R. Dopamin bei der Behandlung der akuten schweren Herzinsuffizienz. Med Welt. 1975 Mar 21;26(12):540–547. [PubMed] [Google Scholar]
  12. Schmidt H. D., Hoppe H., Heidenreich L. Direct effects of dopamine, orciprenaline and norepinephrine on the right and left ventricle of isolated canine hearts. Cardiology. 1979;64(3):133–148. doi: 10.1159/000170611. [DOI] [PubMed] [Google Scholar]
  13. Tarazi R. C., Dustan H. P. Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. Am J Cardiol. 1972 May;29(5):633–640. doi: 10.1016/0002-9149(72)90164-6. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES